Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
BBH Stock Summary
Top 10 Correlated ETFs
BBH
In the News

Should You Invest in the VanEck Biotech ETF (BBH)?
The VanEck Biotech ETF (BBH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.

BBH: Our Favorite Biotech ETF Can Keep Outperforming
VanEck Biotech ETF has outperformed alternative industry ETFs in recent years through its concentration in large-cap leaders. Biotech companies are benefiting from new artificial intelligence tools set to streamline and accelerate R&D programs. We are bullish on biotech stocks, which benefit from significant long-term growth opportunities.

Time for Gilead Sciences-Heavy ETFs?
Bank of America expects the Gilead Sciences to jump about 30%, as quoted on CNBC.

Biotech Still Has Disruptive Capabilities
In what feels like an eternity in biotechnology terms, broader baskets of the industry's stocks haven't outperformed the S&P 500 Health Care Index annually since 2020. That streak could end this year, but biotech stocks and ETFs still aren't on fire.

Should You Invest in the VanEck Biotech ETF (BBH)?
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.

Is Now the Right Time to Embrace Biotech ETFs?
Look if it's the right time to invest in biotech ETFs to help diversify your portfolio.

Biotech ETFs in Focus on Covid Vaccines' Fall Rollout
The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.

Should You Invest in the VanEck Biotech ETF (BBH)?
Launched on 12/20/2011, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

Bevy of Biotech Bargains in BBH
Historically, biotechnology stocks trade at premiums relative to the healthcare and the broader market. That's simply the price of admission investors to pay to access the attractive growth prospects of biotech.

BBH: A Solid Choice For Biotech Exposure
There are several choices for investors interested in biotech exposure through an ETF. Data analysis shows that biotech ETF returns are more sensitive to timing than the S&P500 and have higher probabilities for negative returns.
BBH Financial details
BBH Financial Performance
BBH Frequently Asked Questions
What is VanEck Vectors Biotech ETF stock symbol ?
VanEck Vectors Biotech ETF is a US stock and trading under the symbol BBH
What is VanEck Vectors Biotech ETF stock quote today ?
VanEck Vectors Biotech ETF stock price is $150.55 today.
Is VanEck Vectors Biotech ETF stock public?
Yes, VanEck Vectors Biotech ETF is a publicly traded company.